The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income (loss) | 3,403 | 4,444 | 1,602 | 2,558 |
| Depreciation and amortization expenses | 753 | 714 | 718 | 673 |
| Amortization of premiums and accretion of discounts associated with investments, net | 1,840 | 1,512 | 1,332 | 960 |
| (gains) losses on investments and from sales of businesses, net | -1,144 | -1,165 | -2,800 | -1,262 |
| (gains) losses on derivatives, net | -2,310 | -2,716 | -3,259 | -4,317 |
| (income) loss from equity method investments, net of dividends or distributions | -365 | -844 | -1,090 | -505 |
| Interest credited to policyholder account balances | 9,316 | 8,484 | 7,970 | 3,737 |
| Universal life and investment-type product policy fees | 4,182 | 4,251 | 4,031 | 3,970 |
| Change in contractholder-directed equity securities and fair value option securities | 1,013 | 518 | 539 | -1,671 |
| Change in accrued investment income | 272 | 18 | 194 | 357 |
| Change in premiums, reinsurance and other receivables | 27 | -460 | 1,952 | -256 |
| Change in market risk benefits | 235 | 782 | 658 | - |
| Change in deferred policy acquisition costs and value of business acquired, net | 1,068 | 791 | 660 | 568 |
| Change in income tax | -624 | -484 | -1,177 | -591 |
| Change in other assets | 555 | 0 | 124 | -27 |
| Change in insurance-related liabilities and policy-related balances | 7,257 | 4,079 | 4,637 | 4,058 |
| Change in other liabilities | 1,917 | -580 | 2,115 | 341 |
| Other, net | 443 | 628 | 197 | 245 |
| Net cash provided by (used in) operating activities | 17,092 | 14,598 | 13,721 | 13,204 |
| Sales, maturities and repayments of fixed maturity securities available-for-sale | 59,471 | 55,650 | 58,816 | 88,937 |
| Sales, maturities and repayments of equity securities | 140 | 158 | 1,018 | 873 |
| Sales, maturities and repayments of mortgage loans | 14,646 | 10,363 | 8,505 | 10,779 |
| Sales, maturities and repayments of real estate and real estate joint ventures | 505 | 753 | 143 | 1,096 |
| Sales, maturities and repayments of other limited partnership interests | 1,025 | 1,083 | 915 | 1,615 |
| Sales, maturities and repayments of short-term investments | 16,700 | 11,841 | 13,117 | 14,094 |
| Purchases of fixed maturity securities available-for-sale | 77,614 | 65,667 | 63,460 | 82,956 |
| Purchases of equity securities | 67 | 112 | 73 | 1,368 |
| Purchases of mortgage loans | 10,800 | 8,950 | 8,795 | 16,403 |
| Purchases of real estate and real estate joint ventures | 633 | 1,033 | 1,057 | 1,208 |
| Purchases of other limited partnership interests | 1,416 | 1,401 | 1,670 | 2,674 |
| Purchases of short-term investments | 14,929 | 10,943 | 14,000 | 11,741 |
| Cash received in connection with freestanding derivatives | 2,528 | 2,288 | 3,145 | 4,524 |
| Cash paid in connection with freestanding derivatives | 4,497 | 3,981 | 5,662 | 7,793 |
| Sales of businesses | - | 0 | 0 | 590 |
| Purchases of businesses (net of cash received of 172, 0 and 0, respectively) | 738 | - | - | 35 |
| Payments to acquire interest in joint venture | 236 | 40 | 0 | 240 |
| Net change in policy loans | -21 | -106 | -34 | -104 |
| Net change in other invested assets | -362 | 1,435 | 1,079 | 786 |
| Other, net | 75 | 173 | 143 | 28 |
| Net cash provided by (used in) investing activities | -15,607 | -11,493 | -10,246 | -2,620 |
| Policyholder account balances - deposits | 108,356 | 97,877 | 95,587 | 103,036 |
| Policyholder account balances - withdrawals | 101,508 | 94,914 | 90,876 | 97,886 |
| Net change in payables for collateral under securities loaned and other transactions | -25 | -244 | -3,283 | -10,730 |
| Cash received for other transactions with tenors greater than three months | - | - | - | 0 |
| Cash paid for other transactions with tenors greater than three months | - | - | 0 | 0 |
| Long-term debt issued | 743 | 1,568 | 1,989 | 1,013 |
| Long-term debt repaid | 1,383 | 1,792 | 1,035 | 85 |
| Collateral financing arrangement repaid | 124 | 161 | 79 | 50 |
| Subordinated debt securities issued | 1,000 | - | - | - |
| Derivatives with certain financing elements and other derivative-related transactions, net | 247 | 157 | 74 | 61 |
| Proceeds from mortgage loan secured financing | 439 | 285 | 682 | - |
| Repayments of mortgage loan secured financing | 1,241 | 882 | 845 | - |
| Treasury stock acquired in connection with share repurchases | 2,883 | 3,207 | 3,103 | 3,326 |
| Preferred stock issued, net of issuance costs | - | - | - | 0 |
| Redemption of preferred stock | 988 | - | 0 | 0 |
| Preferred stock redemption premium | 12 | - | 0 | 0 |
| Dividends on preferred stock | 194 | 200 | 198 | 185 |
| Dividends on common stock | 1,509 | 1,527 | 1,566 | 1,598 |
| Other, net | -261 | 223 | -139 | -236 |
| Net cash provided by (used in) financing activities | 163 | -3,131 | -2,940 | -10,108 |
| Effect of change in foreign currency exchange rates on cash and cash equivalents balances | 316 | -545 | -91 | -397 |
| Change in cash and cash equivalents | 1,964 | -571 | 444 | 79 |
| Cash and cash equivalents, including subsidiaries held-for-sale, beginning of year | - | 20,639 | 20,195 | 20,116 |
| Cash and cash equivalents, beginning of year | 20,068 | - | - | - |
| Cash and cash equivalents, including subsidiaries held-for-sale, end of year | - | 20,068 | 20,639 | 20,195 |
| Cash and cash equivalents, end of year | 22,032 | - | - | - |
METLIFE INC (MET-PA)
METLIFE INC (MET-PA)